indazoles has been researched along with Erythema Multiforme in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, R; Pesqué, D; Pujol, RM; Recuero-Borau, J; Tormo-Mainar, S | 1 |
1 other study(ies) available for indazoles and Erythema Multiforme
| Article | Year |
|---|---|
Switching PARP inhibitors as an effective approach for niraparib-induced erythema multiforme.
Topics: Erythema Multiforme; Humans; Indazoles; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors | 2022 |